The human herpesvirus 6 (HHV-6) envelope glycoprotein gH/gL/gQ1/gQ2 complex associates with host cell CD46 as its cellular receptor. Although gB has been suggested to be involved in HHV-6 infection, its function in membrane fusion has remained unclear. Here, we have developed an HHV-6A (strain GS)and HHV-6B (strain Z29) virus-free cell-to-cell fusion assay and demonstrate that gB and the gH/gL/gQ1/gQ2 complex are the minimum components required for membrane fusion by HHV-6.
H
uman herpesvirus 6 (HHV-6), betaherpesvirus subfamily (1), includes two species, A (HHV-6A) and B (HHV-6B) (2) (3) (4) . HHV-6B mainly infects immune cells, such as CD4 ϩ T-lymphocytes, monocytes, and dendritic cells, and also causes exanthema subitum during primary infection in children (5) . HHV-6B can reactivate from latency in immunocompromised patients and cause pneumonitis, hepatitis, and encephalitis (6, 7) . However, the molecular basis of HHV-6A pathogenicity is unclear.
The association of several viral glycoproteins with their respective cellular receptors induces virus envelope-cell membrane fusion during viral entry. It has been reported that HHV-6 gH/gL forms a complex with gQ1 and gQ2 and that this complex binds to CD46, which has been reported to function as a cellular receptor for HHV-6 (8) (9) (10) (11) . gB and a gH/gL complex are conserved in all herpesviruses and thought to play a pivotal role in membrane fusion and herpesvirus infection (12) (13) (14) (15) (16) (17) . Studies of gBs and gHs of other herpesviruses have elucidated the molecular mechanisms of virus envelope-cell membrane fusion (18) (19) (20) (21) . Although some antibodies against HHV-6 gB have been reported to block HHV-6B infection (22, 23) , the function of HHV-6 gB during viral infection remains unclear.
To identify the requirement of HHV-6 glycoproteins for virusinduced membrane fusion during the virus infection, each of the glycoproteins was amplified and expressed from HHV-6B (Z29). Briefly, the genomic sequences of gH, gL, gO, gQ1, and gQ2 were amplified from total DNA of HHV-6B-infected Molt3 cells (Riken BRC, Tsukuba, Japan) and cloned into pCAGGS-MCS expression vector (24) . For detection purposes, the FLAG epitope was inserted in frame at the N termini of gO and gQ2 genes. The fulllength gB gene containing a promoter and poly(A) tail sequences was amplified by recombinant PCR using plasmids containing partial gB sequences (nucleotides [nt] ϩ1 to ϩ1718 and ϩ1713 to ϩ2493). The purified PCR product was used for transient transfection of 293T cells. Expression of transfected genes was analyzed by flow cytometry. gB and the gH/gL complex were detected on the cell surface using anti-gB monoclonal antibody (MAb) and gHA2 antibody, respectively (Fig. 1A) (25) . Cells transfected with plasmid encoding gQ1 or N-terminal FLAG-tagged gQ2 ex- pressed the corresponding proteins. gQ1 and gQ2 were detected intracellularly but not on the cell surface, although they were detected on the surface of cells cotransfected with gH and gL. N-terminal FLAG-tagged gO was also expressed only on the surface of cells cotransfected with gH and gL (data not shown). The level of gB expression on HHV-6B-infected cells was higher than on gBtransfected cells. However, the levels of gH and gQ1 expression on transfected cells were higher than on infected cells (Fig. 1A and B) .
We then generated a flow cytometry analysis that used CD46-Ig fusion protein to analyze HHV-6B glycoproteins that bind to CD46 (26) . CD46-Ig specifically associated with HHV-6B-infected Molt-3 cells but not mock-infected cells (Fig. 1B) . The 293T cells which were transfected with HHV-6 glycoprotein(s) and stained with CD46-Ig showed that CD46-Ig did not bind to cells expressing gH and gL, gB alone, or gH, gL, and gB but did bind to cells transfected with gH, gL, gQ1, and gQ2 (Fig. 1C) . Expression of gB did not affect CD46-Ig binding to cells expressing gH, gL, gQ1, and gQ2. These results suggested that CD46 associated with a gH/gL/gQ1/gQ2 complex on the cell surface.
To identify HHV-6 glycoproteins that mediate membrane fusion, we developed a HHV-6 virus-free cell-to-cell fusion assay. 293T effector cells were cotransfected with the plasmids expressing HHV-6B glycoproteins and a plasmid expressing DsRed or were mock transfected. 293T target cells were cotransfected with plasmid expressing CD46 and green fluorescent protein (GFP) (Fig. 2A) . Effector cells were cocultured with target cells 24 h after transfection. After coculture for 72 h, the cells were analyzed by fluorescence microscopy. As shown in Fig. 2B , yellow, giant, fused cells were observed when effector cells were cotransfected with plasmids expressing HHV-6B gB, gH, gL, gQ1, and gQ2 and cocultured with CD46-transfected target cells. However, no fused cells were found in the absence of gB.
To quantify fusion efficiency, a dual-luciferase reporter assay was used as previously reported (15) . 293T effector cells were cotransfected with plasmid expressing HHV-6B glycoproteins, T7 polymerase (pCAGT7), and Renilla luciferase (as an internal control) and cocultured with 293T target cells transfected with CD46 and T7 promoter-driven firefly luciferase (pT7EMCluc) for 72 h. Firefly and Renilla luciferase activities were then measured, and fusion efficiency was calculated as described in the Fig. 3 legend. The fusion efficiency of varicella-zoster virus (VZV) envelope glycoproteins was measured as a control (15) . Cell-to-cell fusion was 10.2-fold more efficient with gB-, gH-, gL-, gQ1-, and gQ2-transfected effector cells than with mock-transfected effector cells (Fig.  3B) . In the absence of gB, gH, gL, gQ1, or gQ2, no significant fusion activity was observed. gO of human cytomegalovirus (HCMV) and HHV-6 have been suggested to form a complex with gH and gL, with the complex being involved in HCMV entry (9, 27) . However, transfection with HHV-6B gO did not affect cellto-cell fusion induced by HHV-6B gB, gH, gL, gQ1, and gQ2 (data not shown). This is in agreement with the previous report that gO is not essential for HCMV cell-to-cell fusion (27) . CD46-Ig also bound to HHV-6A (strain GS) gH, gL, gQ1, and gQ2 transfectants (data not shown), and cell-to-cell fusion was observed using HHV-6A envelope glycoproteins (Fig. 3A) (28) . Furthermore, cell-to-cell fusion using either HHV-6A or -6B glycoproteins was inhibited by both anti-CD46 and anti-HHV-6A gB MAbs (clone 87-y-13), similar to reports in which syncytium formation by HHV-6A was abrogated by these MAbs (Fig. 4) (29, 30) . These results suggested that both HHV-6A and HHV-6B require gB, gH, gL, gQ1, and gQ2 for cell-to-cell fusion.
Cell-to-cell fusion assays were also done in trans; i.e., some cells were transfected only with plasmid(s) gB, gH/gL, and/or gQ1/gQ2 and other cells were transfected with plasmids expressing all the other glycoproteins. Little cell-to-cell fusion was observed in in trans fusion assays (data not shown). These results suggested that cis expression of HHV-6 gB, gH, gL, gQ1, and gQ2 is required for cell-to-cell fusion, unlike that of herpes simplex virus (HSV) and HCMV, in which all the envelope glycoproteins do not need to be expressed on the same cell (17, 31) . This is the first report showing that the HHV-6A and HHV-6B envelope glycoproteins gB, gH, gL, gQ1, and gQ2 are required for cell-to-cell fusion. Herpesviruses enter via two different pathways: (i) direct fusion of the viral envelope with the host cell membrane or (ii) endocytosis followed by fusion between the viral envelope and endosomal membranes (32) . Since membrane fusion is needed for herpesvirus entry, our results are consistent with previous reports that anti-gB, -gH, and -gQ1 antibodies block HHV-6 infection (22) (23) (24) (33) (34) (35) (36) . Moreover, our results are also supported by an earlier report that gB and gH are required for polykaryocyte formation after virus infection of permissive cells in cell culture (29) . Considering that gBs and gHs of other herpesviruses associate with their respective cellular receptors during viral entry and cell-to-cell fusion (15, 26, (37) (38) (39) (40) (41) , HHV-6 gB may also mediate viral entry and cell-to-cell fusion by interaction with cellular receptors that are currently unknown in addition to the binding of the gH, gL, gQ1, and gQ2 complex to its receptor CD46. The virus-free HHV-6 fusion assay system developed in this study should help elucidate the HHV-6 entry mechanism. 
